Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 2 study of TXA127 for the treatment of stroke recovery.

Next Previous
Trial Profile

A phase 2 study of TXA127 for the treatment of stroke recovery.

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Angiotensin-1-7 (Primary)
  • Indications Stroke
  • Focus Therapeutic Use

    • Most Recent Events

    • 02 Apr 2018 New trial record
    • 27 Mar 2018 According to a Constant Pharmaceuticals media release, company plans to initiate this trial in early 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top